This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A deep dive into the concerns and treatment needs of monkeypox
Ticker(s): BVNRYWho's the expert?
Institution: UC Davis Health
- Professor of Medicine at UC Davis Health Medical Center with a joint appointment in Internal Medicine, Division of Infectious Diseases and the Department of Medical Microbiology and Immunology.
- Specializes in the care of patients with invasive fungal infections and has research interest in clinical trials, fungal diagnostics, and host immunogenetics.
- Research focuses on the development of new antifungal agents, mechanisms of resistance, and molecular causes of adverse side effects.
- Published over 180 papers in peer-reviewed journals, and serves as several national and international committees and advisory boards including the IDSA, Coccidioidomycosis Study Group and the Mycoses Study Group where he chairs the education committee.
Interview GoalWe will be discussing the level of concern and treatment need for this new outbreak. Also, we will learn the safety and efficacy of Bavarian Nordic's monkeypox vaccine.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
